LOGC - LogicBio Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

LOGC is currently covered by 2 analysts with an average price target of $5.19. This is a potential upside of $5.19 (0%) from yesterday's end of day stock price of $0.

LogicBio Therapeutics's activity chart (see below) currently has 3 price targets and 6 ratings on display. The stock rating distribution of LOGC is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 8.33% with an average time for these price targets to be met of 36.5 days.

Highest price target for LOGC is $1, Lowest price target is $1, average price target is $5.19.

Most recent stock forecast was given by SILVAN TUERKCAN from JMP on 10-May-2022.

Best performing analysts who are covering LOGC - LogicBio Therapeutics:

Gena Wang Silvan Tuerkcan Yasmeen Rahimi Geulah Livshits

Currently out of the existing stock ratings of LOGC, 2 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

2

$-0.07 (-3.38%)

16

1 years 10 months 18 days ago

1/3 (33.33%)

$1.54 (334.78%)

146

Buy

8

$5.93 (286.47%)

2 years 4 months 11 days ago

0/1 (0%)

$4.53 (130.55%)

Buy

26

$23.93 (1156.04%)

26

4 years 2 months 18 days ago

0/3 (0%)

$14.67 (150.78%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LOGC (LogicBio Therapeutics) average time for price targets to be met?

On average it took 36.5 days on average for the stock forecasts to be realized with a an average price target met ratio 8.33

Which analyst has the current highest performing score on LOGC (LogicBio Therapeutics) with a proven track record?

GENA WANG

Which analyst has the current lower performing score on LOGC (LogicBio Therapeutics) with a proven track record?

GEULAH LIVSHITS

Which analyst has the most public recommendations on LOGC (LogicBio Therapeutics)?

Gena Wang works at BARCLAYS and has 6 price targets and 3 ratings on LOGC

Which analyst is the currently most bullish on LOGC (LogicBio Therapeutics)?

Yasmeen Rahimi with highest potential upside - $23.93

Which analyst is the currently most reserved on LOGC (LogicBio Therapeutics)?

Silvan Tuerkcan with lowest potential downside - -$0.07

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?